Zhitong Finance and Economics APP, Shanghai Yizhong (688091.SH) issued an announcement, the company officially obtained the "notice of Drug production site Inspection results of Shanghai Drug Administration" on November 19: the company has carried out compliance inspection of drug production quality management standards carried out by Shanghai Drug Administration on April 26-30, 2021, No. 79 Renqi Road, Fengxian District, Shanghai: freeze-dried powder injection (antineoplastic drugs). The inspection results meet the requirements of "Drug production quality Management Standard".
The company's core product, "Paclitaxel Polymer Micelle for injection", completed its first prescription on November 22 and officially launched the sales work.